The use of orthobiologics is gaining increasing interest as a minimally invasive treatment for hip osteoarthritis (OA). The aim of this study was to investigate the evidence about the safety and efficacy of these products. A systematic review of the literature was performed according to the PRISMA and Cochrane guidelines. The study quality was assessed using the RoB 2.0 for randomized controlled trials (RCTs) and the modified Coleman Methodology Score (mCMS) for all studies. A total of 20 clinical studies (735 patients) was identified, 12 on PRP injections and eight on cell-based therapies (five from bone marrow, two from adipose tissue, and one from amniotic fluid). The publication trend increased over time, with over 50% of articles published from 2019. The literature analysis showed only six RCTs, all on PRP injections. The mCMS showed an overall fair methodology (mean score 59.4). While the number of studies and their methodology are still limited, the available evidence suggests safety and overall promising results, with the treatment success being inversely proportional to the severity of OA. Further high-level controlled trials are needed before drawing more definitive conclusions on the real potential of orthobiologics for the injective treatment of patients affected by hip OA.

Zaffagnini, M., Boffa, A., Andriolo, L., Raggi, F., Zaffagnini, S., Filardo, G. (2022). Orthobiologic Injections for the Treatment of Hip Osteoarthritis: A Systematic Review. JOURNAL OF CLINICAL MEDICINE, 11(22), 6663-6679 [10.3390/jcm11226663].

Orthobiologic Injections for the Treatment of Hip Osteoarthritis: A Systematic Review

Zaffagnini, Marco;Boffa, Angelo
;
Andriolo, Luca;Raggi, Federico;Zaffagnini, Stefano;Filardo, Giuseppe
2022

Abstract

The use of orthobiologics is gaining increasing interest as a minimally invasive treatment for hip osteoarthritis (OA). The aim of this study was to investigate the evidence about the safety and efficacy of these products. A systematic review of the literature was performed according to the PRISMA and Cochrane guidelines. The study quality was assessed using the RoB 2.0 for randomized controlled trials (RCTs) and the modified Coleman Methodology Score (mCMS) for all studies. A total of 20 clinical studies (735 patients) was identified, 12 on PRP injections and eight on cell-based therapies (five from bone marrow, two from adipose tissue, and one from amniotic fluid). The publication trend increased over time, with over 50% of articles published from 2019. The literature analysis showed only six RCTs, all on PRP injections. The mCMS showed an overall fair methodology (mean score 59.4). While the number of studies and their methodology are still limited, the available evidence suggests safety and overall promising results, with the treatment success being inversely proportional to the severity of OA. Further high-level controlled trials are needed before drawing more definitive conclusions on the real potential of orthobiologics for the injective treatment of patients affected by hip OA.
2022
Zaffagnini, M., Boffa, A., Andriolo, L., Raggi, F., Zaffagnini, S., Filardo, G. (2022). Orthobiologic Injections for the Treatment of Hip Osteoarthritis: A Systematic Review. JOURNAL OF CLINICAL MEDICINE, 11(22), 6663-6679 [10.3390/jcm11226663].
Zaffagnini, Marco; Boffa, Angelo; Andriolo, Luca; Raggi, Federico; Zaffagnini, Stefano; Filardo, Giuseppe
File in questo prodotto:
File Dimensione Formato  
jcm-11-06663.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.26 MB
Formato Adobe PDF
1.26 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/916956
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 5
social impact